Janus Henderson Group’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-84,510
| Closed | -$8.58M | – | 2430 |
|
|
2025
Q4 | $8.58M | Buy |
84,510
+3,000
| +4% | +$241K | ﹤0.01% | 778 |
|
|
2025
Q3 | $4.46M | Buy |
81,510
+7,408
| +10% | +$370K | ﹤0.01% | 955 |
|
|
2025
Q2 | $3.94M | Buy |
74,102
+60,787
| +457% | +$3.09M | ﹤0.01% | 981 |
|
|
2025
Q1 | $581K | Hold |
13,315
| – | – | ﹤0.01% | 1879 |
|
|
2024
Q4 | $748K | Hold |
13,315
| – | – | ﹤0.01% | 1827 |
|
|
2024
Q3 | $907K | Sell |
13,315
-2,185
| -14% | -$123K | ﹤0.01% | 1723 |
|
|
2024
Q2 | $655K | Sell |
15,500
-328
| -2% | -$18K | ﹤0.01% | 1854 |
|
|
2024
Q1 | $1.09M | Buy |
15,828
+2
| +0% | +$127 | ﹤0.01% | 1593 |
|
|
2023
Q4 | $1.17M | Sell |
15,826
-139
| -0.9% | -$9.11K | ﹤0.01% | 1538 |
|
|
2023
Q3 | $1.09M | Sell |
15,965
-593
| -4% | -$50.3K | ﹤0.01% | 1517 |
|
|
2023
Q2 | $1.55M | Sell |
16,558
-1,638
| -9% | -$128K | ﹤0.01% | 1370 |
|
|
2023
Q1 | $1.23M | Sell |
18,196
-1,317
| -7% | -$84.7K | ﹤0.01% | 1514 |
|
|
2022
Q4 | $966K | Sell |
19,513
-18,721
| -49% | -$765K | ﹤0.01% | 1376 |
|
|
2022
Q3 | $1.24M | Buy |
38,234
+15,200
| +66% | +$627K | ﹤0.01% | 1532 |
|
|
2022
Q2 | $908K | Sell |
23,034
-11,595
| -33% | -$620K | ﹤0.01% | 1382 |
|
|
2022
Q1 | $2.42M | Buy |
+34,629
| New | +$2.53M | ﹤0.01% | 1174 |
|
|
2021
Q4 | – | Sell |
-59,466
| Closed | -$5.68M | – | 2559 |
|
|
2021
Q3 | $5.68M | Sell |
59,466
-1,794
| -3% | -$189K | ﹤0.01% | 1027 |
|
|
2021
Q2 | $7.61M | Buy |
61,260
+1,058
| +2% | +$126K | ﹤0.01% | 980 |
|
|
2021
Q1 | $7.93M | Buy |
60,202
+26,959
| +81% | +$3.69M | ﹤0.01% | 935 |
|
|
2020
Q4 | $4.41M | Sell |
33,243
-28,633
| -46% | -$3.46M | ﹤0.01% | 983 |
|
|
2020
Q3 | $6.31M | Sell |
61,876
-399,386
| -87% | -$34.5M | ﹤0.01% | 895 |
|
|
2020
Q2 | $40.1M | Sell |
461,262
-75,875
| -14% | -$6.06M | 0.02% | 550 |
|
|
2020
Q1 | $31.2M | Buy |
537,137
+15,796
| +3% | +$1.28M | 0.02% | 567 |
|
|
2019
Q4 | $48.2M | Buy |
521,341
+170,576
| +49% | +$15M | 0.02% | 607 |
|
|
2019
Q3 | $31.7M | Buy |
350,765
+323,477
| +1,185% | +$36.9M | 0.02% | 710 |
|
|
2019
Q2 | $3.22M | Buy |
27,288
+22,101
| +426% | +$2.23M | ﹤0.01% | 1104 |
|
|
2019
Q1 | $449K | Buy |
+5,187
| New | +$442K | ﹤0.01% | 1250 |
|
|
2018
Q3 | – | Sell |
-5,000
| Closed | -$299K | – | 1457 |
|
|
2018
Q2 | $299K | Buy |
+5,000
| New | +$269K | ﹤0.01% | 1335 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Janus Henderson Group's EXAS Position: Q1 2026 in Review
Janus Henderson Group sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 84,510 shares — an estimated $8.58M sold.
Janus Henderson Group first reported a position in EXAS in Q2 2018 and held it in 28 quarters. The position peaked at $48.2M in Q4 2019. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Janus Henderson Group reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Janus Henderson Group sold 84,510 Exact Sciences shares in Q1 2026, an estimated $8.58M.
- Janus Henderson Group first reported a position in Exact Sciences in Q2 2018 and held it in 28 quarters.
- Janus Henderson Group's Exact Sciences position peaked at $48.2M in Q4 2019.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.